Hyperspectral imaging in head and neck tumors and malignant non-melanotic skin tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033009

Enrollment

100

Registered

2023-11-16

Start date

2023-09-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant neoplasm of the oral cavity, oropharynx, hypopharynx, larynx non-melanotic skin tumor in the head and neck area C14.8 C10.8 C32.8 C13.8 D23.9

Interventions

Group 1: Patients with (suspected) head and neck tumor Group 2: Patients with (suspected) non-melanotic skin tumors in the head and neck area

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with (suspected) head and neck tumor Patients with (suspected) non-melanotic skin tumor in the head and neck area Written informed consent of the patient to participate in the study

Exclusion criteria

Exclusion criteria: Absence of informed consent

Design outcomes

Primary

Measure	Time frame
The primary aim of the study is to test the suitability of HSI imaging for the acquisition of HSI image data of tumors in vivo.	—

Secondary

Measure	Time frame
The secondary objective is to obtain initial data for the identification of features in the HSI image data that correlate with annotations (pathological findings). This will be used to develop an artificial intelligence (AI) model for tumor diagnostics.	—

Countries

Germany

Contacts

Public ContactOrlando Guntinas-Lichius

Universitätsklinikum Jena, Klinik für Hals-, Nasen- und Ohrenheilkunde

orlando.guntinas@med.uni-jena.de+49 3641 9329301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026